» Articles » PMID: 35326144

Oxidative Stress Related to Plasmalemmal and Mitochondrial Phosphate Transporters in Vascular Calcification

Overview
Date 2022 Mar 25
PMID 35326144
Authors
Affiliations
Soon will be listed here.
Abstract

Inorganic phosphate (Pi) is essential for maintaining cellular function but excess of Pi leads to serious complications, including vascular calcification. Accumulating evidence suggests that oxidative stress contributes to the pathogenic progression of calcific changes. However, the molecular mechanism underlying Pi-induced reactive oxygen species (ROS) generation and its detrimental consequences remain unclear. Type III Na-dependent Pi cotransporter, PiT-1/-2, play a significant role in Pi uptake of vascular smooth muscle cells. Pi influx via PiT-1/-2 increases the abundance of PiT-1/-2 and depolarization-activated Ca entry due to its electrogenic properties, which may lead to Ca and Pi overload and oxidative stress. At least four mitochondrial Pi transporters are suggested, among which the phosphate carrier (PiC) is known to be mainly involved in mitochondrial Pi uptake. Pi transport via PiC may induce hyperpolarization and superoxide generation, which may lead to mitochondrial dysfunction and endoplasmic reticulum stress, together with generation of cytosolic ROS. Increase in net influx of Ca and Pi and their accumulation in the cytosol and mitochondrial matrix synergistically increases oxidative stress and osteogenic differentiation, which could be prevented by suppressing either Ca or Pi overload. Therapeutic strategies targeting plasmalemmal and mitochondrial Pi transports can protect against Pi-induced oxidative stress and vascular calcification.

Citing Articles

Change trends in serum phosphate levels predict in-hospital mortality in critically ill septic patients.

Wang J, Song X, Shi S, Chen L, Jiang L, Ding S Sci Rep. 2025; 15(1):6813.

PMID: 40000730 PMC: 11861283. DOI: 10.1038/s41598-025-90531-0.


Effect of changes trajectory of serum phosphate levels on the 28-day mortality risk in patients with sepsis: a retrospective cohort study from the MIMIC-IV database.

Zhang R, Zhou D BMC Infect Dis. 2025; 25(1):245.

PMID: 39984839 PMC: 11844063. DOI: 10.1186/s12879-025-10547-9.


Editorial Commentary on the Special Issue "Antioxidant Therapy for Cardiovascular Diseases"-Cutting-Edge Insights into Oxidative Stress and Antioxidant Therapy in Cardiovascular Health.

Kwon G, Gibson K, Bi L Antioxidants (Basel). 2024; 13(9).

PMID: 39334693 PMC: 11428301. DOI: 10.3390/antiox13091034.


The Role of Mitochondrial Dysfunction in CKD-Related Vascular Calcification: From Mechanisms to Therapeutics.

Huang J, Hao J, Wang P, Xu Y Kidney Int Rep. 2024; 9(9):2596-2607.

PMID: 39291213 PMC: 11403042. DOI: 10.1016/j.ekir.2024.05.005.


Association between Abdominal Aortic Calcification and Coronary Heart Disease in Essential Hypertension: A Cross-Sectional Study from the 2013-2014 National Health and Nutrition Examination Survey.

He L, Li X, Shen E, He Y J Cardiovasc Dev Dis. 2024; 11(5).

PMID: 38786965 PMC: 11122146. DOI: 10.3390/jcdd11050143.


References
1.
Zhao R, Jiang S, Zhang L, Yu Z . Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int J Mol Med. 2019; 44(1):3-15. PMC: 6559295. DOI: 10.3892/ijmm.2019.4188. View

2.
Liberman M, Bassi E, Martinatti M, Lario F, Wosniak Jr J, Pomerantzeff P . Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 2007; 28(3):463-70. DOI: 10.1161/ATVBAHA.107.156745. View

3.
Ehmke N, Graul-Neumann L, Smorag L, Koenig R, Segebrecht L, Magoulas P . De Novo Mutations in SLC25A24 Cause a Craniosynostosis Syndrome with Hypertrichosis, Progeroid Appearance, and Mitochondrial Dysfunction. Am J Hum Genet. 2017; 101(5):833-843. PMC: 5673623. DOI: 10.1016/j.ajhg.2017.09.016. View

4.
Deng L, Huang L, Sun Y, Heath J, Wu H, Chen Y . Inhibition of FOXO1/3 promotes vascular calcification. Arterioscler Thromb Vasc Biol. 2014; 35(1):175-83. PMC: 4270841. DOI: 10.1161/ATVBAHA.114.304786. View

5.
Yoshida T, Yamashita M, Horimai C, Hayashi M . Smooth Muscle-Selective Nuclear Factor-κB Inhibition Reduces Phosphate-Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease. J Am Heart Assoc. 2017; 6(11). PMC: 5721793. DOI: 10.1161/JAHA.117.007248. View